Ferrous Citrate Fe 59

CHEMBL2106640 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
555.0 g/mol
LogP
Phase
4

A radioactive form of ferrous citrate containing iron-59, used primarily as a diagnostic tracer to study iron metabolism and red blood cell production in research and clinical settings. It is administered under strict medical supervision due to its radioactive properties.

الوزن الجزيئي

555,0000 g/mol

TPSA

281,00 Ų

آلية العمل

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[59Fe+2].[59Fe+2].[59Fe+2]

InChI

InChI=1S/2C6H8O7.3Fe/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6/i;;3*1+3

Molecular Formula

C12H10Fe3O14

HBD / HBA

2 / 14

الروابط القابلة للدوران

4

الذرات الثقيلة

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A radioactive form of ferrous citrate containing iron-59, used primarily as a diagnostic tracer to study iron metabolism and red blood cell production in research and clinical settings. It is administered under strict medical supervision due to its radioactive properties.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Ferrous Citrate Fe 59 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2106640. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11353432. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.